Cardinal Well being Groups Up with Palantir to Ship a Clinically Built-in Provide Chain Resolution

Cardinal Well being (NYSE: CAH) introduced right this moment that it has entered right into a strategic collaboration with Palantir Applied sciences Inc. (Palantir) (NYSE: PLTR), a number one builder of working techniques for the trendy enterprise, to design an answer that can give well being techniques and hospitals dynamic buy choice insights to be able to shortly enhance their backside line.

The Cardinal Well being answer, which might be built-in into Foundry, Palantir’s industry-leading working system, will deploy synthetic intelligence (AI) and machine studying (ML) to carry collectively analysis and scientific knowledge with real-time buyer buying and consumption knowledge for pharmaceutical merchandise with best-in-class knowledge and privateness protections. Future iterations of the instrument are anticipated to assist inform buying selections for therapeutic utilization, reimbursement insights and predictive drug stock wants – to assist additional enhance the connection between well being system buying and provide chain help.

“We’re taking a proactive position in pharmaceutical choice help to offer help to our clients as they proceed to handle rising drug bills, provide chain volatility and continued drug shortages,” stated Peter J. Siavelis, senior vp and common supervisor of Well being System and Supplier Distribution & Providers at Cardinal Well being. “By using Palantir’s platform, we’re working to reshape the pharmaceutical provide chain with progressive processes, merchandise and options to enhance entry to crucial drugs and streamline pharmacy stock administration.”

As hospitals steadiness will increase in drug bills as a result of development of specialty therapies and biosimilars, well being techniques are struggling to right-size pharmacy stock along with continually evolving payer formulary updates. Cardinal Well being’s data-driven answer will mitigate a few of these challenges by analyzing real-time scientific and buying knowledge to successfully create a clinically-integrated provide chain for prescription drugs.

“Our partnership with Cardinal Well being additional exhibits our dedication to enhance affected person outcomes throughout the complete healthcare worth chain and Palantir’s means to create resilience inside the complicated challenges of provide chain uncertainty,” stated Palantir chief working officer Shyam Sankar.  “We’re excited to work with Cardinal Well being to realize their mission-critical goal of increasing entry to the drugs sufferers want, by using the software program constructed to deal with the hardest issues.”

A pacesetter within the knowledge and analytics {industry}, Palantir launched its Well being & Life Sciences division in 2020. Since then, the corporate has continued to help federal, private and non-private organizations and is a confirmed chief in delivering mission-critical software program throughout the general public well being provide chain.

About Cardinal Well being 
Cardinal Well being is a distributor of prescription drugs, a world producer, and distributor of medical and laboratory merchandise, and a supplier of efficiency, and knowledge options for healthcare amenities. With greater than 50 years in enterprise, operations in additional than 30 nations and roughly 46,500 workers globally, Cardinal Well being is important to care. Details about Cardinal Well being is on the market at

About Palantir Applied sciences Inc.
Foundational software program of tomorrow. Delivered right this moment. Extra info is on the market at

Ahead-Wanting Statements
This press launch incorporates forward-looking statements inside the that means of Part 27A of the Securities Act of 1933, as amended, and Part 21E of the Securities Alternate Act of 1934, as amended. These statements could relate to, however usually are not restricted to, Palantir’s expectations relating to the quantity and the phrases of the contract and the anticipated advantages of our software program platforms. Ahead-looking statements are inherently topic to dangers and uncertainties, a few of which can’t be predicted or quantified. Ahead-looking statements are primarily based on info out there on the time these statements are made and had been primarily based on present expectations in addition to the beliefs and assumptions of administration as of that point with respect to future occasions. These statements are topic to dangers and uncertainties, a lot of which contain elements or circumstances which are past our management. These dangers and uncertainties embrace our means to fulfill the distinctive wants of our clients; the failure of our platforms to fulfill our clients or carry out as desired; the frequency or severity of any software program and implementation errors; our platforms’ reliability; and our buyer’s means to switch or terminate the contract. Extra info relating to these and different dangers and uncertainties is included within the filings we make with the Securities and Alternate Fee on occasion. Besides as required by regulation, we don’t undertake any obligation to publicly replace or revise any forward-looking assertion, whether or not because of new info, future developments, or in any other case.

Media Contacts

Tara Parsell, [email protected]
Lisa Gordon, [email protected]

SOURCE Cardinal Well being

Leave a Reply